US Patent Issued to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Urbana, Illinois on June 16 for "Anticancer compounds selective for ER-positive cancers" (Illinois, Massachusetts Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,104, issued on June 16, was assigned to THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Urbana, Illinois (Urbana, Ill.).

"Anticancer compounds selective for ER-positive cancers" was invented by Paul J. Hergenrother (Champaign, Ill.) and Matthew Boudreau (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Small molecule ERAlpha biomodulators that kill therapy-resistant ERa positive breast, ovarian, and endometrial cancer cells are disclosed. In one embodiment, the small molecule biomodulator has increased therapeutic utility because of an increased ability to kill therapy-resistant cancer cells compared to BHPI and other conventional th...